Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

New automated image analysis method for the assessment of Ki-67 labeling index in meningiomas.

Grala B, Markiewicz T, Kozłowski W, Osowski S, Słodkowska J, Papierz W.

Folia Histochem Cytobiol. 2009;47(4):587-92. doi: 10.2478/v10042-008-0098-0.

2.

Automated nuclear segmentation in the determination of the Ki-67 labeling index in meningiomas.

Kim YJ, Romeike BF, Uszkoreit J, Feiden W.

Clin Neuropathol. 2006 Mar-Apr;25(2):67-73.

PMID:
16550739
3.

Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas.

Mukherjee S, Ghosh SN, Chatterjee U, Chatterjee S.

Neurol India. 2011 Nov-Dec;59(6):817-22. doi: 10.4103/0028-3886.91357.

PMID:
22234191
4.

Proliferative potential of recurrent intracranial meningiomas as evaluated by labelling indices of BUdR and Ki-67, and tumour doubling time.

Kakinuma K, Tanaka R, Onda K, Takahashi H.

Acta Neurochir (Wien). 1998;140(1):26-31; discussion 31-2.

PMID:
9522904
5.

Accuracy of a remote quantitative image analysis in the whole slide images.

Słodkowska J, Markiewicz T, Grala B, Kozłowski W, Papierz W, Pleskacz K, Murawski P.

Diagn Pathol. 2011 Mar 30;6 Suppl 1:S20. doi: 10.1186/1746-1596-6-S1-S20.

6.

Content-based analysis of Ki-67 stained meningioma specimens for automatic hot-spot selection.

Swiderska-Chadaj Z, Markiewicz T, Grala B, Lorent M.

Diagn Pathol. 2016 Oct 7;11(1):93.

7.

[Expression of HER2/neu in meningiomas: an immunohistochemistry and fluorescence in situ hybridization study].

Wang CL, Mei JH, Wang SS, Xu S, Xu LL, Xiong YF.

Zhonghua Bing Li Xue Za Zhi. 2010 Mar;39(3):156-60. Chinese.

PMID:
20450760
8.

The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.

Roser F, Samii M, Ostertag H, Bellinzona M.

Acta Neurochir (Wien). 2004 Jan;146(1):37-44; discussion 44. Epub 2003 Dec 22.

PMID:
14740263
9.

PCNA, Ki-67 and hTERT in residual benign meningiomas.

Maes L, Kalala JP, Cornelissen M, De Ridder L.

In Vivo. 2006 Mar-Apr;20(2):271-5.

10.

Characterization of morphologically benign biologically aggressive meningiomas.

Rao S, Sadiya N, Doraiswami S, Prathiba D.

Neurol India. 2009 Nov-Dec;57(6):744-8. doi: 10.4103/0028-3886.59470.

11.

Hot-spot selection and evaluation methods for whole slice images of meningiomas and oligodendrogliomas.

Swiderska Z, Markiewicz T, Grala B, Slodkowska J.

Conf Proc IEEE Eng Med Biol Soc. 2015;2015:6252-6. doi: 10.1109/EMBC.2015.7319821.

PMID:
26737721
12.

Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.

Lanzafame S, Torrisi A, Barbagallo G, Emmanuele C, Alberio N, Albanese V.

Pathol Res Pract. 2000;196(7):483-8.

PMID:
10926326
13.

Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics.

Kolles H, Niedermayer I, Schmitt C, Henn W, Feld R, Steudel WI, Zang KD, Feiden W.

Acta Neurochir (Wien). 1995;137(3-4):174-81.

PMID:
8789658
14.

Correlation of apparent diffusion coefficient with Ki-67 proliferation index in grading meningioma.

Tang Y, Dundamadappa SK, Thangasamy S, Flood T, Moser R, Smith T, Cauley K, Takhtani D.

AJR Am J Roentgenol. 2014 Jun;202(6):1303-8. doi: 10.2214/AJR.13.11637.

PMID:
24848829
15.

Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.

Ozen O, Demirhan B, Altinörs N.

Clin Neuropathol. 2005 Sep-Oct;24(5):219-24.

PMID:
16167545
16.

Computerized determination of proliferating cell nuclear antigen expression in meningiomas. A comparison with non-automated method.

Konstantinidou A, Patsouris E, Kavantzas N, Pavlopoulos PM, Bouropoulou V, Davaris P.

Gen Diagn Pathol. 1997 Jun;142(5-6):311-6.

PMID:
9228254
17.

Comparison between Ki67 labeling index determined using image analysis software with virtual slide system and that determined visually in breast cancer.

Maeda I, Abe K, Koizumi H, Nakajima C, Tajima S, Aoki H, Tsuchiya J, Tsuchiya S, Tsuchiya K, Shimo A, Tsugawa K, Ueno T, Tatsunami S, Takagi M.

Breast Cancer. 2016 Sep;23(5):745-51. doi: 10.1007/s12282-015-0634-7. Epub 2015 Aug 14.

PMID:
26271611
18.

The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study.

Abry E, Thomassen IØ, Salvesen ØO, Torp SH.

Pathol Res Pract. 2010 Dec 15;206(12):810-5. doi: 10.1016/j.prp.2010.09.002. Epub 2010 Oct 15.

PMID:
20951502
19.

Automated recognition and counting of the immunoreactive neuroendocrine cells in chronic gastritis (the preliminary study).

Markiewicz T, Jochymski C, Slodkowska J, Kozlowski W.

Folia Histochem Cytobiol. 2009;47(4):685-90. doi: 10.2478/v10042-008-0099-z.

20.

Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases.

Fukushima S, Terasaki M, Sakata K, Miyagi N, Kato S, Sugita Y, Shigemori M.

Brain Tumor Pathol. 2009;26(2):51-7. doi: 10.1007/s10014-009-0249-9. Epub 2009 Oct 27.

PMID:
19856215

Supplemental Content

Support Center